Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23326,81,0.90 [0.63-1.28],0.561229247142834
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23820,124,1.03 [0.81-1.32],0.8070141893609486
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23610,866,1.13 [1.04-1.23],0.0031901001026271
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Candidiasis,23844,264,1.06 [0.90-1.24],0.4759536225160051
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23161,2357,1.03 [0.97-1.09],0.3182874873365408
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23377,1763,0.98 [0.92-1.05],0.5841126430870095
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23668,842,0.98 [0.89-1.08],0.671608444074161
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23773,36,1.29 [0.92-1.81],0.1327382463365326
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22758,550,1.09 [0.98-1.21],0.1283213858888923
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21982,524,1.15 [1.03-1.27],0.0102382468017128
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22206,148,1.07 [0.87-1.33],0.5166979519323373
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17735,1032,1.05 [0.97-1.14],0.2400664479991076
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22008,245,1.10 [0.94-1.30],0.2266739413068198
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23808,982,0.98 [0.90-1.08],0.7231594208989858
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Mycoses,23900,320,1.04 [0.90-1.21],0.574929888230604
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23268,524,1.09 [0.98-1.22],0.1116567665322359
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23847,602,1.08 [0.97-1.20],0.1440621461362516
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22952,126,1.05 [0.83-1.33],0.6945266454967995
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23939,25,1.32 [0.90-1.93],0.1521656489922043
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23776,531,1.10 [0.99-1.23],0.0826271503749788
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23801,64,0.85 [0.56-1.29],0.4588641770782518
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23850,151,1.12 [0.91-1.36],0.2813650659872079
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23836,137,1.13 [0.92-1.39],0.2594006640169561
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23042,298,1.19 [1.04-1.36],0.0105171998820543
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22946,202,1.18 [1.00-1.39],0.0480980145308508
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22890,64,0.92 [0.63-1.34],0.6710681928967359
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23912,45,0.92 [0.58-1.45],0.7136406423405346
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23885,112,0.95 [0.72-1.26],0.7111961850879105
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral warts,23812,39,1.05 [0.68-1.61],0.8352327248006984
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23815,42,0.80 [0.47-1.36],0.406087639275055
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm,23692,269,0.94 [0.78-1.13],0.5212817106243837
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23864,62,0.80 [0.51-1.24],0.3146136811922374
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23840,67,0.99 [0.70-1.40],0.9415264484819128
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10695,37,1.07 [0.69-1.65],0.7722702276173138
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23763,997,1.07 [0.98-1.16],0.1157230279910976
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of meninges,23928,42,0.77 [0.45-1.34],0.35985439621566
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23907,46,0.89 [0.56-1.43],0.6281454024941645
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23918,78,0.81 [0.55-1.20],0.2876267950314508
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of ovary,13188,85,0.83 [0.58-1.19],0.3065783797258498
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23930,238,1.06 [0.89-1.26],0.5092589170170692
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Caecum,23928,178,1.17 [0.99-1.39],0.0679701324385715
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23872,44,0.74 [0.42-1.30],0.2910440860784543
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Descending colon,23933,149,1.19 [0.98-1.43],0.0752889772765055
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Rectum,23901,246,1.16 [1.00-1.35],0.0487788070416128
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23870,462,0.97 [0.85-1.11],0.6960537571259606
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23931,263,1.04 [0.88-1.23],0.6542016355685166
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Carcinoma in situ of breast,11312,75,0.71 [0.46-1.10],0.1246169727181364
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11351,84,0.81 [0.56-1.18],0.271635102245599
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20656,27,0.39 [0.14-1.07],0.0681341297100347
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20662,33,0.62 [0.30-1.28],0.1979134927928444
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23898,96,1.21 [0.97-1.51],0.0884180795296631
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Haemangioma, any site",23898,94,1.21 [0.97-1.52],0.0856587062363369
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Leiomyoma of uterus,12629,354,0.94 [0.81-1.10],0.4327092919771094
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Lung cancer and mesothelioma,17751,157,0.98 [0.78-1.23],0.8492098197656147
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Lymphoid leukaemia,20655,26,0.53 [0.21-1.30],0.1653502251013791
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20756,127,1.09 [0.87-1.36],0.4681755769444725
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20705,76,0.60 [0.37-0.98],0.0432429090483584
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11399,68,1.05 [0.77-1.44],0.7482900480411447
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20673,44,0.93 [0.59-1.46],0.7464778556158238
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20678,49,0.92 [0.59-1.43],0.696115378419167
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20691,62,1.26 [0.97-1.63],0.0865111227775945
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11379,48,1.11 [0.79-1.56],0.5512298313358637
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20677,48,0.65 [0.36-1.16],0.1445688204960138
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9644,346,1.01 [0.87-1.18],0.913507152753831
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20713,84,0.99 [0.73-1.34],0.947331001518814
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20676,47,1.10 [0.76-1.58],0.6179373980987298
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20684,55,0.86 [0.55-1.34],0.4968029842898962
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanocytic naevi,23733,187,1.20 [1.02-1.41],0.0239918321623289
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanocytic naevi of trunk,23897,85,1.28 [1.03-1.59],0.0233691810459795
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanoma in situ,20638,38,1.04 [0.67-1.60],0.8689132622304024
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20681,52,0.80 [0.49-1.30],0.3597742656676951
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20725,96,1.00 [0.75-1.33],0.9946641455627996
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20734,105,0.94 [0.71-1.25],0.6735787402157615
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20683,54,0.88 [0.57-1.35],0.549255958299657
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Other benign neoplasms of skin,23779,128,1.01 [0.79-1.29],0.9199081996940792
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21178,549,0.97 [0.86-1.10],0.6044020105465893
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21206,577,0.97 [0.86-1.09],0.6238093063721464
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23690,263,1.01 [0.85-1.19],0.933608172979752
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22708,41,0.70 [0.39-1.28],0.2505838346327151
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23492,65,0.69 [0.42-1.12],0.1312331365646215
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23239,1924,1.00 [0.94-1.07],0.9757249369536684
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22934,20,0.73 [0.31-1.68],0.4547826780305432
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23632,28,1.01 [0.59-1.71],0.9729772441086764
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23546,879,1.03 [0.94-1.13],0.5254783581686691
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23546,879,1.03 [0.94-1.13],0.5254783581686691
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22716,49,1.17 [0.85-1.61],0.3252881964210649
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23700,786,0.99 [0.89-1.09],0.8210041622328487
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23696,92,1.00 [0.74-1.34],0.9786094735144714
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23475,48,1.07 [0.73-1.57],0.7338147485908832
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23465,38,0.93 [0.57-1.52],0.7830794333149538
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23771,167,1.04 [0.84-1.28],0.7342736570253292
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23871,58,0.99 [0.68-1.44],0.9757290248471924
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23748,144,0.99 [0.78-1.25],0.9280718427465674
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22976,62,1.06 [0.76-1.46],0.736677017196543
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20544,173,1.11 [0.92-1.34],0.2917779845279932
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22239,105,0.96 [0.71-1.30],0.8012446352524093
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22256,122,1.13 [0.90-1.42],0.2803538364562451
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20402,31,1.61 [1.27-2.06],0.0001137632019406
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22208,63,0.75 [0.47-1.20],0.2333506088168588
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21905,123,0.87 [0.65-1.17],0.3585886187821743
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23814,139,0.99 [0.78-1.26],0.9422889005188296
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23721,46,0.98 [0.65-1.49],0.939061086088405
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23706,31,0.76 [0.40-1.45],0.4046560695246132
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23588,1443,0.93 [0.86-1.01],0.0758658090868533
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21439,1402,0.93 [0.86-1.01],0.0901107898129629
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20405,34,1.18 [0.78-1.77],0.4299329530036405
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22510,51,1.01 [0.69-1.49],0.9510864958239836
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20531,160,1.05 [0.85-1.30],0.6360585761396501
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20424,53,1.03 [0.70-1.50],0.8993886368905318
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22450,2079,1.00 [0.94-1.07],0.9380369160569406
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20479,108,1.19 [0.96-1.48],0.119922836038154
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20707,336,1.04 [0.90-1.21],0.5747607833571107
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23854,225,0.82 [0.65-1.03],0.0822189171789117
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23716,87,0.67 [0.44-1.03],0.0676793958550164
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20461,90,0.76 [0.52-1.12],0.1708304524587017
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20405,34,1.57 [1.22-2.00],0.0003440128473062
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23568,1109,0.98 [0.90-1.06],0.5653437721144441
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20481,110,1.06 [0.82-1.36],0.6759777658660278
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20501,130,1.13 [0.91-1.40],0.2820704289816608
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20717,346,0.98 [0.84-1.14],0.7783914897935069
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20424,53,0.73 [0.44-1.23],0.2343456343837294
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23711,82,0.61 [0.38-0.97],0.0365117512429785
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20630,259,0.97 [0.81-1.17],0.7713766284436788
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20637,266,1.00 [0.84-1.19],0.9869829684475832
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21833,51,0.82 [0.51-1.33],0.4227281033894425
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23330,2959,0.98 [0.93-1.04],0.5357165269734314
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22485,26,0.46 [0.18-1.19],0.1086348241508012
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22511,52,1.29 [0.99-1.68],0.0563352887221491
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23779,1681,0.97 [0.90-1.05],0.4483290281572859
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23782,1678,0.98 [0.91-1.05],0.5183464138169396
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22490,31,1.33 [0.95-1.85],0.0961403218413684
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23661,1067,0.90 [0.81-0.99],0.0240511465240521
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21138,767,1.01 [0.91-1.11],0.916322186177391
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23931,110,1.04 [0.80-1.35],0.7496569932672146
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23704,29,0.98 [0.57-1.67],0.9272247152375106
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22672,78,0.87 [0.60-1.25],0.4465771404307415
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22691,97,0.98 [0.74-1.31],0.9005582302298507
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20480,109,0.98 [0.74-1.28],0.8708638172907635
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22374,106,1.07 [0.83-1.37],0.6160803011389624
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1489,57,1.21 [0.85-1.72],0.2816480913213447
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1585,165,1.15 [0.92-1.44],0.2107848514580766
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22304,36,1.07 [0.66-1.73],0.7792160539038495
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1463,31,0.96 [0.51-1.81],0.8948937197976072
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23580,1312,0.94 [0.87-1.03],0.1828936103414674
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23735,60,0.98 [0.68-1.41],0.9230501690391676
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22026,244,0.90 [0.73-1.10],0.2940033408929189
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20718,347,0.94 [0.80-1.11],0.4603709348697393
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23860,149,0.94 [0.73-1.20],0.6037077276548647
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23283,47,1.27 [0.96-1.69],0.0902932776236084
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Angina pectoris,22831,700,1.05 [0.95-1.16],0.317568138513972
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23326,90,1.30 [1.06-1.60],0.0128773396344277
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23266,30,0.74 [0.37-1.46],0.3834640878063488
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23332,96,1.10 [0.85-1.42],0.4775907453848769
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16983,783,1.00 [0.90-1.10],0.9521471836417472
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,AV-block,21795,158,1.04 [0.84-1.30],0.6953045964011102
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23909,225,0.99 [0.82-1.19],0.895465617519396
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cardiac arrest,16294,94,1.02 [0.77-1.36],0.8827153621686396
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21748,111,1.04 [0.80-1.35],0.7641632597872912
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21706,69,0.93 [0.65-1.35],0.7128988213147329
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23941,15,0.95 [0.44-2.05],0.8892011109016561
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Conduction disorders,22100,463,1.01 [0.89-1.16],0.8318044146483787
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23290,1169,1.03 [0.95-1.11],0.5339670677956385
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22224,5246,0.98 [0.94-1.02],0.3428831613346578
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22936,157,0.94 [0.73-1.19],0.5903304567386705
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Endocarditis,21678,41,1.21 [0.84-1.73],0.3054719542206815
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23832,451,1.16 [1.04-1.29],0.0086116735128811
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypertension,22724,4268,0.97 [0.93-1.01],0.143156072155558
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22733,4277,0.97 [0.92-1.01],0.1319189348981194
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23783,48,1.15 [0.81-1.63],0.4457269522451368
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18532,76,0.91 [0.64-1.29],0.6073637154481918
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18498,42,0.92 [0.58-1.48],0.7419248044130302
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypotension,23850,597,1.09 [0.98-1.21],0.1171064325839382
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23477,54,0.90 [0.58-1.38],0.6200148763682776
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23438,1307,1.04 [0.97-1.13],0.2523370237318773
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23742,269,1.00 [0.84-1.18],0.9829792425521312
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21819,182,1.02 [0.83-1.25],0.8585768880921599
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23717,529,1.05 [0.93-1.17],0.452445063725634
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22561,430,1.06 [0.93-1.20],0.3824813290272679
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23892,105,0.85 [0.61-1.18],0.3413207322461379
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23926,184,1.05 [0.86-1.28],0.6478773453784004
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Oesophageal varices,22809,30,1.42 [1.03-1.97],0.0339757435008367
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other aneurysm,23277,41,1.14 [0.79-1.66],0.4861822890033029
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other arrhythmias,21858,221,1.02 [0.84-1.23],0.8745247970921152
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23297,61,1.02 [0.71-1.44],0.9332177155623902
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23365,129,1.12 [0.90-1.38],0.3044253442907182
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21749,112,1.05 [0.81-1.35],0.7199492074909497
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other disorders of veins,22840,61,1.10 [0.80-1.52],0.5578335247459072
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22824,45,0.99 [0.64-1.51],0.9504570440392732
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23265,32,0.72 [0.36-1.42],0.3404903293583091
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22859,80,1.01 [0.74-1.38],0.9580568442403646
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22144,507,1.13 [1.01-1.26],0.0361066241620616
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23293,40,1.23 [0.87-1.74],0.2358329667526381
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23540,304,1.02 [0.87-1.20],0.7830002076919969
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23544,135,0.96 [0.75-1.23],0.7645632227704123
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23436,203,1.04 [0.86-1.26],0.6638121960444019
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16412,212,1.05 [0.87-1.26],0.6108120351483295
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23395,180,1.13 [0.94-1.36],0.2008831528155052
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22994,215,0.96 [0.79-1.18],0.7135282984790619
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23700,291,0.88 [0.73-1.06],0.1737755182021464
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23902,279,1.10 [0.95-1.28],0.2098499664148456
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21784,147,0.95 [0.74-1.22],0.6625609169286892
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23541,132,0.97 [0.76-1.24],0.817024018602563
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23333,100,1.18 [0.94-1.48],0.1522993264480426
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23735,312,0.98 [0.83-1.15],0.8234091625734531
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23712,345,0.98 [0.84-1.14],0.7519032025153557
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23456,47,1.00 [0.67-1.49],0.9821946902927432
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23285,50,1.17 [0.84-1.63],0.3590001306101821
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23590,117,0.88 [0.65-1.18],0.3873602027204024
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23348,160,0.89 [0.69-1.15],0.3559898772416996
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Varicose veins,23049,270,1.06 [0.91-1.25],0.4484895790595172
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23245,42,0.89 [0.55-1.46],0.6525678870646365
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23786,452,0.93 [0.81-1.08],0.3364851725359684
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23797,322,1.11 [0.97-1.28],0.1380078519989636
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21299,1220,0.88 [0.80-0.96],0.0043508325595842
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Any mental disorder,23281,3202,0.94 [0.89-0.99],0.0138076550074608
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23743,376,1.06 [0.93-1.22],0.3959212001545276
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21549,1470,0.92 [0.85-1.00],0.0488328150415182
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20156,77,1.11 [0.83-1.47],0.4871825495104449
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Smoking dependency,23467,1346,0.99 [0.91-1.07],0.7436132816580867
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21624,1545,0.97 [0.90-1.04],0.4211626507127657
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Vascular dementia,23841,16,0.66 [0.24-1.83],0.4221662451675023
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Alzheimer disease,23940,64,0.96 [0.67-1.38],0.8283350043258016
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Bell's palsy,22479,65,0.76 [0.49-1.20],0.2459496855865976
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22839,425,0.95 [0.82-1.09],0.4485404900676224
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Cerebral cysts,23627,171,0.86 [0.67-1.11],0.2410393461427312
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23862,191,1.01 [0.82-1.23],0.9353024116171272
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23807,21,0.96 [0.52-1.77],0.894665029764958
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23929,49,1.09 [0.75-1.56],0.6602281045587999
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23505,49,0.88 [0.56-1.40],0.5993376630890939
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Epilepsy,22587,227,0.93 [0.76-1.14],0.4983587938883406
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23514,1154,0.96 [0.88-1.04],0.3233923571575135
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23913,166,0.90 [0.70-1.15],0.3803117578764319
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23500,1449,1.04 [0.97-1.11],0.2730886824851617
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Generalized epilepsy,23617,48,0.86 [0.53-1.39],0.5376769014346013
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Hemiplegia,23813,142,1.13 [0.92-1.38],0.2406299626266603
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Hydrocephalus,23498,42,0.43 [0.20-0.92],0.0308547160190827
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23919,60,0.74 [0.46-1.20],0.2221261770667758
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22483,69,1.35 [1.09-1.68],0.0064563583677337
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22485,71,1.25 [0.97-1.60],0.0813446390550911
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Memory loss,23811,66,0.79 [0.51-1.23],0.2959784799477518
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Migraine,22722,362,0.92 [0.78-1.08],0.2841577125808519
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23863,328,0.94 [0.80-1.11],0.4703860940203039
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Motor neuron disease,17404,91,0.64 [0.42-0.99],0.0443505195575884
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23750,132,0.82 [0.61-1.10],0.1754004459196232
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23411,997,0.95 [0.87-1.05],0.3301826600090198
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Neurological diseases,22671,2641,0.94 [0.88-0.99],0.0323062311010852
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23855,69,1.27 [0.99-1.62],0.0586587588877232
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22757,343,1.01 [0.87-1.17],0.9258022700546488
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23879,200,0.96 [0.78-1.19],0.7299112344283749
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19972,281,0.92 [0.77-1.11],0.3880325842179358
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23508,52,0.93 [0.61-1.42],0.7295850060789153
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23559,103,0.91 [0.67-1.24],0.5447004993651487
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23817,70,0.92 [0.64-1.33],0.6651524433180667
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22497,83,0.81 [0.55-1.19],0.2876523073798572
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other headache syndromes,22413,53,0.77 [0.47-1.27],0.307593088903402
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other neurological diseases,23837,381,0.92 [0.78-1.07],0.2758006195298574
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other sleep disorders,22871,511,1.05 [0.92-1.18],0.4814671078410869
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Parkinson's disease,23927,75,0.83 [0.56-1.24],0.3669452388041954
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23509,53,0.77 [0.47-1.26],0.3033018215609698
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Restless leg syndrome,23939,32,0.90 [0.52-1.56],0.6984638722906362
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Sleep apnoea,23725,444,1.03 [0.90-1.18],0.6364140541611897
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23711,32,0.70 [0.35-1.41],0.3207940033190115
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23924,115,0.63 [0.43-0.93],0.0209167260343839
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22440,26,0.90 [0.70-1.14],0.383264041294137
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23940,65,0.98 [0.68-1.39],0.8952262599541781
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23829,15,0.71 [0.26-1.95],0.5090135267452027
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23524,35,0.75 [0.40-1.39],0.3618897981527996
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23626,180,0.83 [0.65-1.07],0.1476474438867858
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23867,169,1.06 [0.86-1.31],0.5809867903476054
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23282,33,0.78 [0.42-1.44],0.4268512065323763
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23316,67,0.82 [0.54-1.25],0.3564665286183258
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23857,26,1.14 [0.71-1.83],0.5867128345047682
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23773,53,0.89 [0.58-1.36],0.5927160895155132
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1465,33,0.96 [0.52-1.77],0.8903642461966322
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1734,68,1.14 [0.81-1.60],0.4691546936874888
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23559,70,0.80 [0.53-1.22],0.2975976085818011
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23832,538,0.92 [0.80-1.05],0.2113674426886619
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23667,418,0.97 [0.85-1.12],0.7096408451224139
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23372,123,0.94 [0.73-1.23],0.6633609308739294
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23857,411,1.02 [0.89-1.16],0.8079627439952043
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23933,50,0.64 [0.35-1.14],0.1305715722737275
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23790,344,0.99 [0.85-1.15],0.9109862234143378
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23905,185,1.00 [0.82-1.23],0.995261212952212
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23882,119,0.89 [0.67-1.19],0.4382051074618167
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23264,15,1.51 [1.05-2.17],0.0276725306226887
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23275,26,1.15 [0.73-1.79],0.5508363836334483
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23279,30,0.88 [0.50-1.55],0.6594176629919006
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23898,335,0.96 [0.81-1.12],0.5845437982765769
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23647,84,0.89 [0.63-1.25],0.4944902996493541
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23467,21,1.12 [0.67-1.89],0.6569606815523863
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23781,61,1.17 [0.87-1.56],0.3047058891012709
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23846,126,0.93 [0.72-1.22],0.6085893551002651
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23590,144,1.12 [0.92-1.37],0.2662881827084381
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23831,68,1.02 [0.73-1.41],0.9217489586639542
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23781,218,1.01 [0.84-1.22],0.8883550052379322
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23584,95,0.99 [0.74-1.32],0.9237185661327872
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23323,942,1.07 [0.99-1.16],0.0941632094848195
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23824,104,0.82 [0.59-1.15],0.2494071557353498
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23920,99,1.04 [0.80-1.37],0.7567577323643241
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23478,229,0.98 [0.82-1.18],0.8595527570886637
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23756,36,1.26 [0.90-1.77],0.173337088632361
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23917,34,0.53 [0.24-1.17],0.1164029260057009
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23282,33,0.37 [0.15-0.92],0.032702091524247
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23351,102,0.97 [0.73-1.29],0.8464043651091371
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23348,54,1.47 [1.19-1.82],0.0003226021975506
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23494,48,1.05 [0.72-1.53],0.7933903738957145
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23340,46,0.54 [0.28-1.05],0.0706695232898863
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23609,46,0.86 [0.53-1.38],0.5265050453401281
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23640,77,0.96 [0.69-1.34],0.8080071255900035
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23323,74,1.20 [0.93-1.54],0.1559056051564762
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23401,107,0.92 [0.68-1.23],0.5627753545968681
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23324,30,0.72 [0.36-1.44],0.3584821872208985
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23098,717,0.98 [0.88-1.09],0.6789239210489801
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23293,44,1.12 [0.79-1.58],0.5327019191335332
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23750,261,0.89 [0.74-1.09],0.263019647142213
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23520,31,1.01 [0.61-1.67],0.970001723067219
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23599,110,1.02 [0.78-1.32],0.9070188417030136
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23760,55,1.32 [1.02-1.70],0.0325863828661086
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23899,81,0.87 [0.60-1.25],0.4408887068634942
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23830,123,0.82 [0.60-1.12],0.2149428686748395
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23754,49,0.94 [0.62-1.44],0.7851267544395844
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23757,52,1.09 [0.76-1.54],0.6472763743504379
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23857,468,0.99 [0.87-1.13],0.9177562833845088
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23675,286,1.05 [0.89-1.23],0.5677522007210313
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23477,88,1.09 [0.83-1.43],0.527466497136863
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23455,66,1.15 [0.87-1.53],0.3285557732446452
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute pharyngitis,23679,69,0.95 [0.66-1.36],0.7675989214078914
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23825,215,0.99 [0.82-1.21],0.9522868234282846
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23669,59,0.66 [0.39-1.12],0.1241012026464276
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,All influenza,22826,67,0.95 [0.66-1.36],0.7724635143059733
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22825,66,0.96 [0.67-1.38],0.841543752329406
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17711,117,0.92 [0.69-1.23],0.5857569145464061
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Allergic rhinitis,23813,274,0.92 [0.76-1.10],0.3546967425753066
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18997,1537,1.00 [0.93-1.07],0.9351951670154446
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19101,1507,1.01 [0.94-1.09],0.7876425568237355
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23696,84,0.97 [0.71-1.33],0.8541759140007237
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22808,49,1.00 [0.67-1.49],0.9990318228498672
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Bronchiectasis,21283,153,1.19 [0.99-1.42],0.0569131089840729
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21164,34,0.76 [0.40-1.41],0.3805462894361981
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23177,2047,1.02 [0.96-1.08],0.5594575031474375
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22648,59,0.82 [0.52-1.29],0.3898567575400066
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Chronic sinusitis,22730,141,0.95 [0.74-1.23],0.7143257681318456
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23851,630,0.99 [0.88-1.11],0.8358132528302503
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Deviated nasal septum,22707,118,0.77 [0.55-1.08],0.1367673039052518
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22257,3686,0.99 [0.95-1.04],0.7507219798950909
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22925,336,1.06 [0.92-1.23],0.4036859667676209
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Early onset COPD,23666,445,0.96 [0.83-1.10],0.5513531407780647
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Emphysema,21293,163,1.17 [0.98-1.41],0.0795559510086532
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22815,99,0.96 [0.72-1.29],0.7990726022528906
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23783,1024,1.04 [0.95-1.13],0.3814830865424491
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Interstitial lung disease,22837,121,0.92 [0.70-1.21],0.5439632923144875
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Later onset COPD,22674,185,1.04 [0.86-1.26],0.6980147746114356
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23933,131,1.11 [0.90-1.38],0.3247514499508847
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Nasal polyp,22691,102,0.94 [0.69-1.27],0.6753548647851834
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23748,550,1.03 [0.92-1.15],0.6458187441727616
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other diseases of pleura,23783,1089,1.01 [0.93-1.10],0.7881105540232891
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23368,779,1.00 [0.90-1.11],0.9838861781722504
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other pleural conditions,22726,32,0.98 [0.59-1.63],0.9465487889663592
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23888,177,0.96 [0.77-1.20],0.714557588103581
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23866,738,1.02 [0.92-1.13],0.6618576163427092
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pleural effusion,23217,523,1.04 [0.92-1.17],0.5415824764428425
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pleural plaque,22742,48,1.11 [0.77-1.60],0.5720719772120672
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23600,841,1.00 [0.90-1.10],0.9291910369442612
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23917,115,1.06 [0.83-1.35],0.6609351780502184
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pneumothorax,22750,56,0.59 [0.33-1.06],0.0770175315757593
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pollen allergy,23910,235,0.91 [0.75-1.12],0.3899929710116244
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pulmonary oedema,23746,35,0.85 [0.48-1.50],0.58109161950513
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17627,33,0.95 [0.56-1.60],0.8496951946646523
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23728,530,1.03 [0.92-1.16],0.61775776900611
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22863,274,0.92 [0.76-1.11],0.3619211156988068
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Viral pneumonia,22921,162,1.22 [1.03-1.46],0.0252933353792684
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23711,140,1.25 [1.03-1.51],0.0216425434331843
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13802,86,1.24 [0.98-1.59],0.0779786695085313
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18326,57,1.04 [0.72-1.51],0.8217581733881187
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute appendicitis,23763,131,0.95 [0.73-1.23],0.6927322752150598
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute gastritis,19122,62,1.13 [0.84-1.53],0.4282953064932383
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute pancreatitis,22535,149,0.82 [0.62-1.09],0.1784916404021755
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute peritonitis,23549,58,0.95 [0.64-1.41],0.7984635171988987
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23269,76,1.10 [0.82-1.48],0.5145769572970924
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Barrett oesophagus,19366,306,0.87 [0.72-1.05],0.153880977293149
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22433,47,1.36 [1.05-1.76],0.0207408549343756
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23593,47,1.35 [1.05-1.76],0.0214488982428578
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Cholecystitis,22539,153,1.30 [1.11-1.53],0.0012721864804092
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Cholelithiasis,23215,829,1.04 [0.94-1.14],0.4675522669723673
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Chronic gastritis,19274,214,1.07 [0.89-1.27],0.475297920044616
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22422,36,1.12 [0.74-1.68],0.5982358505723775
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23811,76,1.24 [0.97-1.59],0.0894045571965644
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Coeliac disease,22696,94,1.16 [0.92-1.47],0.2113748191143065
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Collagenous colitis,22579,43,0.81 [0.48-1.37],0.4383030288220839
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23773,181,1.05 [0.86-1.28],0.6598361440026826
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Constipation,23744,1010,1.06 [0.98-1.15],0.143799036924398
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Crohn disease,22612,76,0.63 [0.39-1.02],0.0593632369413417
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23639,50,0.75 [0.44-1.26],0.273039950332183
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22609,73,0.85 [0.58-1.26],0.4244177230403388
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Dental caries,23217,229,1.06 [0.89-1.26],0.5058513734314227
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22112,1554,1.00 [0.94-1.08],0.9110473472211724
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of appendix,23801,169,0.93 [0.74-1.17],0.5455732583356967
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of liver,23833,640,1.04 [0.93-1.16],0.4901825263477604
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22413,3353,0.97 [0.93-1.02],0.3077473331493687
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23515,527,1.00 [0.89-1.13],0.9821797655198196
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23863,372,0.94 [0.80-1.10],0.4146190395146523
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23098,110,0.98 [0.74-1.29],0.8881875912281341
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22962,58,0.87 [0.56-1.33],0.5080383829061016
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23692,1090,1.01 [0.93-1.10],0.8676240228390852
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of tongue,22968,106,0.72 [0.49-1.04],0.0793899464184244
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23497,1111,1.02 [0.93-1.10],0.721912078295226
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20379,2110,1.00 [0.94-1.07],0.8935712953725358
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Duodenal ulcer,19188,128,0.83 [0.61-1.12],0.2176832323679074
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23874,100,0.86 [0.62-1.20],0.3726188934209613
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23824,71,0.94 [0.66-1.33],0.7227424377860698
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23286,93,1.28 [1.03-1.59],0.023291626921156
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18425,156,1.03 [0.83-1.29],0.7797259462965681
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Functional dyspepsia,19507,447,0.97 [0.85-1.11],0.6681985629037732
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastric ulcer,19312,252,0.90 [0.74-1.10],0.2980646075016426
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21018,1958,0.98 [0.91-1.04],0.4588033968551563
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19425,365,0.86 [0.72-1.02],0.0863173880013449
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19472,6942,1.00 [0.96-1.03],0.8031006242987029
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,GI-bleeding,23478,876,1.00 [0.91-1.10],0.9880751372144824
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23047,59,1.20 [0.90-1.59],0.2182718662999634
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19056,1104,0.99 [0.90-1.07],0.7392136156031648
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23237,44,1.02 [0.67-1.56],0.9289668558701816
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Hernia,22912,2354,0.98 [0.92-1.04],0.4295547087266783
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Impacted teeth,23833,66,0.94 [0.65-1.35],0.7307058777813464
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Impaction of intestines,18301,32,1.16 [0.76-1.75],0.4939858333513214
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Inguinal hernia,21154,596,0.89 [0.78-1.02],0.098531530512914
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20629,71,0.91 [0.62-1.33],0.6279988752670985
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18329,60,0.81 [0.52-1.27],0.3601834806303599
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22716,114,1.15 [0.92-1.42],0.2219697490559121
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18765,496,0.90 [0.79-1.04],0.1515619923833806
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23915,332,1.00 [0.85-1.17],0.9746477871667368
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23140,604,0.99 [0.88-1.11],0.8749186247251847
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23295,759,0.94 [0.84-1.05],0.2604402695496443
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19185,125,1.00 [0.78-1.29],0.9730816416244288
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oesophagitis,19481,421,1.01 [0.88-1.16],0.8650712451980012
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23901,116,1.08 [0.85-1.36],0.529719609289742
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20601,43,0.59 [0.30-1.14],0.1149541221489186
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19397,1128,0.92 [0.84-1.01],0.0923143056317471
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22555,169,1.12 [0.93-1.35],0.2283092698737422
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22526,140,1.14 [0.93-1.39],0.2106704694846848
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of intestine,19584,1315,0.99 [0.91-1.07],0.7692771474685779
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of intestines,22490,4221,0.97 [0.92-1.01],0.1455820209551759
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22967,166,1.04 [0.85-1.28],0.7102744461405949
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of liver,23708,515,1.02 [0.91-1.16],0.7142093063297588
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19529,469,0.89 [0.77-1.03],0.1330346452690569
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22460,74,0.77 [0.51-1.17],0.2254505360181882
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23818,327,0.93 [0.79-1.10],0.4084972809541346
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19727,667,1.04 [0.93-1.15],0.5000808146351408
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23490,888,0.99 [0.90-1.09],0.8820060891466287
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23134,146,0.91 [0.70-1.17],0.4516143004663326
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19321,1052,1.06 [0.98-1.15],0.1756906603779875
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20592,1532,0.98 [0.91-1.05],0.5655099828801007
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23263,70,1.18 [0.90-1.55],0.2312318270334227
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23196,660,0.98 [0.87-1.09],0.6859595495892752
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18476,207,0.87 [0.70-1.09],0.2386823704882957
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23808,83,1.00 [0.74-1.35],0.9997472662532354
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18572,303,0.84 [0.69-1.01],0.0695481649961079
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22723,121,0.93 [0.71-1.23],0.6302888562231955
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23930,53,0.95 [0.63-1.43],0.8076554247116018
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22999,112,1.12 [0.89-1.41],0.3408501448352133
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Toxic colitis,22558,22,1.15 [0.70-1.90],0.5844214348076562
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19230,170,0.96 [0.77-1.21],0.7491782349143985
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ulcerative colitis,22666,130,0.68 [0.48-0.96],0.0277680092425891
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22649,113,0.68 [0.47-0.98],0.0405352106708733
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Umbilical hernia,20793,235,0.99 [0.82-1.20],0.9033939839185958
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18361,92,0.83 [0.59-1.19],0.3119225832935384
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ventral hernia,20761,203,1.00 [0.82-1.23],0.968746406047713
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Volvulus,18325,56,0.99 [0.68-1.44],0.955464824056098
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23899,136,0.99 [0.77-1.26],0.9106021881395644
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23708,74,0.78 [0.52-1.18],0.2386397743440614
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22668,133,1.15 [0.94-1.41],0.1791945205324581
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23385,484,1.02 [0.90-1.16],0.704157418429092
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23080,179,1.03 [0.83-1.26],0.804206671424831
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22684,149,0.99 [0.78-1.26],0.9465517450126518
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23714,201,1.03 [0.85-1.25],0.7518907624324898
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23854,341,1.08 [0.94-1.24],0.2668952532977414
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23552,39,1.38 [1.03-1.85],0.03139390288044
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22676,2242,1.02 [0.96-1.08],0.5138871371453964
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23539,377,1.05 [0.92-1.21],0.4505661045573151
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23426,264,1.01 [0.85-1.20],0.9177770540814332
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23599,698,1.02 [0.91-1.13],0.759903478676656
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23928,42,0.82 [0.49-1.38],0.4661965041543578
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22590,55,1.20 [0.89-1.61],0.2410425144813761
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23200,38,1.25 [0.88-1.79],0.2174687281199077
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23708,195,1.03 [0.85-1.25],0.7429645937524487
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22789,254,1.02 [0.86-1.21],0.8213161237292876
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22567,32,0.58 [0.27-1.26],0.1682059600573779
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23865,65,1.13 [0.85-1.52],0.4006021708889465
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23018,117,0.81 [0.58-1.12],0.1980748781424161
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23764,130,0.84 [0.62-1.13],0.2416317003279419
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23537,24,0.79 [0.38-1.64],0.5203247518314817
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22581,46,0.67 [0.37-1.21],0.1826196413589411
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23497,962,1.05 [0.97-1.15],0.2266686283437212
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22819,284,0.98 [0.83-1.17],0.8465201800471327
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22571,36,0.62 [0.31-1.25],0.1846033303622042
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23870,236,0.81 [0.64-1.01],0.0634300111909474
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23567,54,1.27 [0.97-1.68],0.0828641770589888
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23826,192,0.81 [0.63-1.04],0.0983159393836285
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23913,150,0.95 [0.75-1.21],0.679699143405853
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22647,112,1.09 [0.86-1.38],0.4603126726062887
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22696,161,1.17 [0.98-1.40],0.0753212057266947
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23907,144,0.97 [0.76-1.23],0.7877280517538446
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22648,113,1.05 [0.81-1.36],0.7058048581251729
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23908,108,1.10 [0.87-1.40],0.428031721628947
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20970,117,1.09 [0.86-1.37],0.4698064747344379
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22313,4040,0.96 [0.92-1.00],0.0754098772243996
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21139,2866,0.95 [0.90-1.00],0.0435883401864774
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20937,84,0.98 [0.72-1.34],0.8933455982521372
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21457,137,1.03 [0.82-1.30],0.7974356722208417
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21465,145,0.92 [0.71-1.19],0.5300504847328547
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23733,105,1.03 [0.79-1.34],0.8377199764867435
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21361,41,1.05 [0.71-1.57],0.7977982528524524
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18931,658,0.96 [0.86-1.08],0.5140293335754382
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23882,113,0.77 [0.55-1.08],0.126582958106934
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21567,247,0.99 [0.83-1.19],0.9459211840324692
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20904,5427,0.95 [0.91-0.99],0.01152072515043
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22717,101,0.97 [0.73-1.30],0.8400897335630403
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20959,106,1.04 [0.80-1.35],0.7821853602611768
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21396,543,1.01 [0.90-1.14],0.8237091328497635
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23163,1843,1.00 [0.94-1.07],0.9151232774774096
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21056,203,1.02 [0.84-1.23],0.872484806755267
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21110,257,1.04 [0.89-1.23],0.6088046140838768
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20989,136,1.02 [0.81-1.28],0.8956141755526561
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23472,34,0.71 [0.37-1.36],0.2988818761873691
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19402,1129,0.87 [0.79-0.96],0.0047991387163417
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18608,335,1.04 [0.89-1.21],0.6303056356921211
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23891,326,1.06 [0.91-1.23],0.4775948540115164
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18338,65,1.05 [0.76-1.44],0.7697837684007258
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18576,303,0.80 [0.66-0.98],0.0269369393753962
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21138,285,1.00 [0.85-1.18],0.9854801228738724
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18943,670,0.90 [0.79-1.01],0.0749894583843885
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21344,24,0.59 [0.24-1.42],0.2390878639837767
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21814,494,0.99 [0.87-1.12],0.857089416708975
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21573,253,1.02 [0.86-1.21],0.8010040956381865
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18895,622,0.87 [0.76-0.99],0.0297916701672282
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20922,69,0.84 [0.56-1.26],0.3962967102943173
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20907,54,1.05 [0.73-1.50],0.7966625323973372
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22670,54,1.19 [0.85-1.64],0.3094727756876041
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23650,1034,1.01 [0.93-1.10],0.8459680374609537
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23201,585,1.02 [0.91-1.13],0.7827319034235873
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23836,305,1.09 [0.94-1.25],0.2546546031229338
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19833,1560,0.97 [0.90-1.04],0.3377206008840291
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18338,65,0.97 [0.68-1.39],0.8595910870619021
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20921,68,1.07 [0.78-1.45],0.675469927409684
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18299,26,1.31 [0.90-1.91],0.1519895409739366
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18374,101,0.86 [0.63-1.18],0.3524234961041439
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22828,212,0.98 [0.81-1.20],0.8696713041252279
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22832,216,1.04 [0.87-1.24],0.6560057447837625
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23904,75,0.89 [0.62-1.28],0.5277873433208351
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22706,1386,0.99 [0.91-1.07],0.7379855765070626
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20962,109,1.09 [0.86-1.37],0.4866295118513051
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18385,112,0.67 [0.46-0.97],0.0316437100970053
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21874,554,1.00 [0.88-1.12],0.957550603281619
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20063,1790,0.94 [0.88-1.01],0.0785781791737887
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23488,50,0.78 [0.47-1.29],0.3303871718752754
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23918,69,0.77 [0.50-1.18],0.2321639142891832
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20922,69,1.05 [0.77-1.43],0.7500546991212591
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21819,966,0.91 [0.83-1.01],0.0737861713264183
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20914,61,1.22 [0.93-1.60],0.1523685030648541
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19257,984,1.03 [0.94-1.12],0.5479244915308403
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22713,97,0.93 [0.68-1.26],0.6278613886518593
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20911,58,1.08 [0.78-1.50],0.6418257476166036
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21423,103,1.01 [0.77-1.32],0.9569027314883528
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21201,348,0.89 [0.75-1.05],0.1684800795509042
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23624,186,1.12 [0.94-1.33],0.2010069374359078
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21740,420,0.96 [0.83-1.11],0.5726859052772054
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23843,290,1.11 [0.96-1.28],0.147074506638746
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23924,34,1.20 [0.83-1.74],0.3427119931178007
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21033,180,1.12 [0.94-1.35],0.2024478763389576
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19191,534,0.98 [0.86-1.11],0.7253706823123384
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21286,433,0.90 [0.77-1.04],0.1633676835981304
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21003,150,0.93 [0.73-1.19],0.5739934952515767
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18307,34,0.98 [0.61-1.58],0.9360516961596094
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19821,1548,1.04 [0.97-1.11],0.2811561110636447
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18670,397,0.92 [0.79-1.07],0.263295139707096
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23513,75,0.99 [0.71-1.36],0.9315332561881708
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23873,44,1.15 [0.81-1.62],0.4303126225365581
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22548,26,1.01 [0.59-1.72],0.9776440536795152
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18344,71,0.81 [0.54-1.22],0.3135783026876075
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21404,84,0.79 [0.53-1.16],0.2310424344769451
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18582,309,1.05 [0.91-1.21],0.5155464815048083
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21092,239,0.95 [0.78-1.15],0.5806955408518226
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21508,188,0.97 [0.79-1.20],0.8087901330675165
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21410,90,1.12 [0.87-1.43],0.3773551392605809
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20242,43,1.03 [0.70-1.52],0.8709632472917825
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23927,37,1.12 [0.76-1.66],0.5577278683583977
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21377,524,0.99 [0.88-1.12],0.8578526063856534
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23516,78,1.28 [1.02-1.59],0.0292894371929519
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22990,2137,0.96 [0.90-1.02],0.1586962547559782
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20953,100,0.88 [0.64-1.21],0.4403041722012027
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21632,312,0.89 [0.74-1.06],0.1991591979362514
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22705,167,1.09 [0.90-1.32],0.382092367342024
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21449,129,1.02 [0.80-1.29],0.8664614035593126
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22254,934,1.00 [0.91-1.09],0.9613561127390056
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21933,613,0.98 [0.87-1.10],0.6839436463533825
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20892,39,0.99 [0.63-1.55],0.952465832891228
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23576,138,1.22 [1.02-1.47],0.0297151150569323
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20990,137,0.77 [0.57-1.04],0.0914595359061697
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20906,53,0.81 [0.51-1.28],0.3610391349978041
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18305,32,1.06 [0.66-1.71],0.8105632759631132
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23492,734,1.07 [0.97-1.17],0.1918415673540516
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9697,64,0.98 [0.69-1.38],0.8869145466068589
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12911,70,0.99 [0.71-1.38],0.943417280651295
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23683,271,1.03 [0.87-1.22],0.7100244396358368
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23468,56,0.86 [0.55-1.35],0.5096720986998414
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23308,550,1.04 [0.93-1.17],0.4465087108039668
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23786,19,0.54 [0.19-1.52],0.2408806371781391
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23793,163,1.13 [0.94-1.37],0.2010806173546893
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Cystitis,21987,133,1.10 [0.88-1.37],0.4042898313593633
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Dialysis,22799,41,0.95 [0.60-1.52],0.8347731068989241
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10359,973,1.04 [0.95-1.13],0.4488574277658507
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13013,172,0.91 [0.72-1.15],0.427783143789195
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Endometriosis,9747,114,0.76 [0.55-1.06],0.1089580980386662
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9970,337,0.97 [0.83-1.13],0.6672912440891572
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10014,381,0.92 [0.79-1.07],0.2892075093437621
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20188,3679,1.01 [0.96-1.06],0.672774368694139
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23822,55,1.23 [0.92-1.64],0.1571228135654223
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Hydrocele,9453,67,1.24 [0.93-1.64],0.1357098388696549
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22676,192,0.99 [0.80-1.21],0.8907236868451575
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10040,654,0.91 [0.80-1.04],0.1660246714101522
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12903,206,1.01 [0.84-1.22],0.8993627868079417
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9477,91,1.10 [0.83-1.44],0.5126110910938672
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Irregular menses,12912,109,1.09 [0.86-1.37],0.4772903605275264
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9896,263,0.98 [0.82-1.16],0.7835167646784948
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21908,54,1.22 [0.91-1.65],0.1844838471244252
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10868,1235,0.94 [0.86-1.02],0.1311029308263556
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9431,45,1.06 [0.70-1.62],0.7694848171902255
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9718,85,1.04 [0.79-1.37],0.7936000904273921
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23930,35,0.84 [0.47-1.48],0.5442012588706597
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23935,38,1.11 [0.75-1.66],0.5942543419306778
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23182,1328,1.03 [0.95-1.11],0.4770166764841538
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22267,413,1.01 [0.88-1.16],0.8568970780108023
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12896,55,0.99 [0.69-1.44],0.9734745086864562
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23893,263,1.08 [0.92-1.26],0.3547924384036656
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9523,137,0.98 [0.75-1.27],0.8668800266864549
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9488,102,1.17 [0.92-1.50],0.2019484900455589
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9452,66,1.19 [0.89-1.59],0.2409048747881728
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23907,47,1.03 [0.70-1.52],0.8663103042871214
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22828,974,1.04 [0.96-1.14],0.3249497157557934
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12804,107,1.02 [0.79-1.32],0.8673772693107984
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9706,73,1.13 [0.87-1.48],0.3616597682205176
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9840,207,1.11 [0.94-1.31],0.234756781711695
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9686,53,1.08 [0.77-1.52],0.6534966692758137
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9724,91,1.14 [0.90-1.45],0.2857130473510619
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22705,221,0.98 [0.80-1.19],0.8138054837928703
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23718,88,1.20 [0.95-1.52],0.1243796392423444
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9790,157,0.94 [0.75-1.18],0.598626404394317
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9701,68,0.81 [0.54-1.22],0.3068197543237631
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10003,370,1.03 [0.90-1.18],0.7133553836414556
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9689,56,0.99 [0.68-1.42],0.9445015030572058
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9965,332,0.92 [0.78-1.08],0.308317276908464
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23806,39,1.08 [0.72-1.62],0.6936942603265777
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9474,88,1.23 [0.97-1.57],0.0929654782451205
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23782,1298,1.03 [0.95-1.11],0.5066504338399291
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22610,126,1.13 [0.91-1.39],0.269307500412949
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22815,57,1.01 [0.69-1.46],0.9778857111996468
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23472,60,1.03 [0.72-1.47],0.873619495766879
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22006,152,0.85 [0.64-1.11],0.2353311304426592
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23740,328,0.98 [0.83-1.15],0.8085924741980592
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9718,85,0.86 [0.61-1.22],0.3992025799994539
